The tablets are used for the prevention and management of postpartum hemorrhage (PPH), a condition characterized by excessive bleeding during labor. Lupin has bolstered its portfolio by introducing ...

Lupin Pharmaceuticals has announced the re-introduction of Methergine (methylergonovine maleate) Oral Tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Lupin ...

Drug firm Lupin has strengthened its brand portfolio in the US market with the introduction of its Methergine oral tablets used for the prevention and management of excess blood loss after delivery, ...

(RTTNews) - Hikma Pharmaceuticals PLC (HIK.L) announced that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp., has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic ...

The only FDA-approved oral uterotonic for the management of PPH, comes to market with a significant investment in professional medical education to improve care Pharma Major Lupin Limited and its US ...

Lupin and its US subsidiary have re-introduced Methergine (methylergonovine maleate) oral tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only ...

Granules India Ltd today said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership with West-Ward Pharmaceuticals Corp, a wholly-owned ...

Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., has launched the generic version of methylergonovine maleate tablets, USP, 0.2mg the generic equivalent to ...

London, 30 May 2018 - Hikma Pharmaceuticals PLC (Hikma, Group) (LSE: HIK) (NASDAQ Dubai: HIK) (OTC: HKMPY) (rated Ba1 Moody's / BB+ S&P, both stable) announces that its wholly-owned US subsidiary, ...